Mark Federici’s Post
More Relevant Posts
-
GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology
https://venturebeat.com
To view or add a comment, sign in
-
Cardurion Raises $260M to Advance Cardiovascular Assets
biospace.com
To view or add a comment, sign in
-
Waypoint Bio Raises $14.5M in Seed Funding
https://www.finsmes.com
To view or add a comment, sign in
-
Alumis cuts IPO size, but nets $250M for immune drug work
biopharmadive.com
To view or add a comment, sign in
-
Elegen Raises $35M in Series B Funding
https://www.finsmes.com
To view or add a comment, sign in
-
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer's Disease at Discovery Europe 2024
hjnews.com
To view or add a comment, sign in
-
Huge launch
Xaira Therapeutics Launches with $1 Billion in Funding and Stellar Team
https://thehealthcaretechnologyreport.com
To view or add a comment, sign in
-
Sands Capital raises $555M fund amid upturn in biotech ‘crossover’ investing
biopharmadive.com
To view or add a comment, sign in
-
Ajax, aiming for a better JAK drug, raises $95M to begin first tests
biopharmadive.com
To view or add a comment, sign in
-
Outstanding success and another step forward for gene therapy medicine
Regeneron gene therapy improves hearing in two children
biopharmadive.com
To view or add a comment, sign in
Ophthalmic Technician at Starling Physicians - retired
3moGreat article